B

Bioretec Oy
OMXH:BRETEC

Watchlist Manager
Bioretec Oy
OMXH:BRETEC
Watchlist
Price: 0.455 EUR -1.3% Market Closed
Market Cap: €14m

Operating Margin

-102.6%
Current
Declining
by 10.9%
vs 3-y average of -91.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-102.6%
=
Operating Income
€-5.4m
/
Revenue
€5.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-102.6%
=
Operating Income
€-5.4m
/
Revenue
€5.3m

Peer Comparison

Country Company Market Cap Operating
Margin
FI
Bioretec Oy
OMXH:BRETEC
14.2m EUR
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.3B USD
Loading...
US
Abbott Laboratories
NYSE:ABT
187.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
138.8B USD
Loading...
US
Stryker Corp
NYSE:SYK
135B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.2B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.6B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...

Market Distribution

Lower than 95% of companies in Finland
Percentile
5th
Based on 625 companies
5th percentile
-102.6%
Low
-41 526.1% — 1.5%
Typical Range
1.5% — 10.8%
High
10.8% — 59.4%
Distribution Statistics
Finland
Min -41 526.1%
30th Percentile 1.5%
Median 5.5%
70th Percentile 10.8%
Max 59.4%

Bioretec Oy
Glance View

Market Cap
14m EUR
Industry
Health Care

Bioretec Ltd. develops bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. The company is headquartered in Tampere, Lansi-Suomen. The company went IPO on 2021-09-28. The firm operates as a developer, manufacturer and commercializer of innovative bioresorbable orthopedic implants and implant materials used for the treatment of bone and soft tissue injuries. Bioretec Oy’s existing Activa product portfolio consists of bioabsorbable biopolymer products that are alreadyavailable in the market for applications in pediatrics, trauma surgery as well as sports surgery. Bioretec Oy has one Germany-based subsidiary, BRI.Tech GmbH. The Company’s products are used all over the world.

BRETEC Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-102.6%
=
Operating Income
€-5.4m
/
Revenue
€5.3m
What is Bioretec Oy's current Operating Margin?

The current Operating Margin for Bioretec Oy is -102.6%, which is below its 3-year median of -91.7%.

How has Operating Margin changed over time?

Over the last 3 years, Bioretec Oy’s Operating Margin has decreased from -77.9% to -102.6%. During this period, it reached a low of -134.5% on Jun 30, 2025 and a high of -65.7% on Jun 30, 2023.

Back to Top